Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review

Date: July 12, 2017
Pages: 37
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: NAB21C8878CEN
Leaflet:

Download PDF Leaflet

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review
Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Nipro Corp (Nipro) manufactures, develops and markets pharmaceutical, medical and glass products. The company’s products include renal products, interventional and anesthesiology products, injection and infusion products, cardiopulmonary products, double bags, pre-filled syringes, half-type kits among others. It offers contract manufacturing services in various dosage forms, including injectables, external preparations, orally administerd drugs and primary-packaging pharmaceutical containers. Nipro also provides glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; other parts of pharmaceutical packaging including rubber plugs; and glass bulbs for vacuum flasks. The company has its factories and sales offices across North America, South America, Europe, Asia, and Africa regions. Nipro is headquartered in Osaka, Japan.

Nipro Corp Key Recent Developments

Jun 06,2016: GHIT Fund Welcomes Ten New Partnerships With FUJIFILM, Otsuka, GSK, Johnson & Johnson, Kyowa Hakko Kirin, Merck, Mitsubishi Tanabe, Nipro, Sumitomo Dainippon Pharma and Salesforce.com

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Nipro Corp - Key Facts
Nipro Corp - Key Employees
Nipro Corp - Major Products and Services
Nipro Corp - History
Nipro Corp - Company Statement
Nipro Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Nipro Corp - Business Description
Nipro Corp - Corporate Strategy
Nipro Corp - SWOT Analysis
SWOT Analysis - Overview
Nipro Corp - Strengths
Nipro Corp - Weaknesses
Nipro Corp - Opportunities
Nipro Corp - Threats
Nipro Corp - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Nipro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Nipro Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
Nipro Corp, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Mar 21, 2016: HealthLink Europe & International Opens A New FDA Registered, 100% Medical Warehouse Facility In Tennessee

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Nipro Corp, Key Facts
Nipro Corp, Key Employees
Nipro Corp, Major Products and Services
Nipro Corp, History
Nipro Corp, Other Locations
Nipro Corp, Subsidiaries
Nipro Corp, Joint Venture
Nipro Corp, Key Competitors
Nipro Corp, Ratios based on current share price
Nipro Corp, Annual Ratios
Nipro Corp, Annual Ratios (Cont.1)
Nipro Corp, Annual Ratios (Cont.2)
Nipro Corp, Interim Ratios
Nipro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Nipro Corp, Medical Equipment, Deals By Type, 2011 to YTD 2017
Nipro Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Nipro Corp, Performance Chart (2013 - 2017)
Nipro Corp, Ratio Charts
Nipro Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
Nipro Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Terumo Corp
Fresenius SE & Co KGaA
B. Braun Melsungen AG
Asahi Kasei Medical Co Ltd
Ansell Limited
Skip to top


Ask Your Question

Nipro Corp (8086) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: